Home Cart Sign in  
Chemical Structure| 1186206-79-0 Chemical Structure| 1186206-79-0

Structure of ALW-II-41-27
CAS No.: 1186206-79-0

Chemical Structure| 1186206-79-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ALW-II-41-27 is an Eph family tyrosine kinase inhibitor with an IC50 of 11 nM for Eph2.

Synonyms: Eph receptor tyrosine kinase inhibitor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ALW-II-41-27

CAS No. :1186206-79-0
Formula : C32H32F3N5O2S
M.W : 607.69
SMILES Code : CC1=C(NC(C2=CC(C3=CC=CS3)=CN=C2)=O)C=C(C(NC4=CC=C(CN5CCN(CC)CC5)C(C(F)(F)F)=C4)=O)C=C1
Synonyms :
Eph receptor tyrosine kinase inhibitor
MDL No. :MFCD25372028

Safety of ALW-II-41-27

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of ALW-II-41-27

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW macrophages 100 ug/mL 60 minutes ALW-II-41-27 significantly inhibited Pc β-glucan-induced phosphorylation of both p38 and ERK1/2 and reduced TNF-alpha release PMC10848750
Mouse lung alveolar macrophages 100 ug/mL 60 minutes ALW-II-41-27 significantly reduced TNF-alpha cytokine release from primary mouse lung alveolar macrophages induced by Pc β-glucans PMC10848750
NCM460 colonic cells 50, 100, 200, 400 ng/mL 24 hours ALW-II-41-27 significantly reversed LPS-induced oxidative stress and inflammation PMC5890185
KLE cells 1 µM and 10 µM 4 hours Inhibition of EphA2 receptor significantly reduced Vd1 T cell-mediated killing of KLE cells PMC8529280
Ishikawa cells 1 µM 4 hours In EphA2-negative Ishikawa cells, ALW-II-41-27 did not significantly reduce cell killing PMC8529280
Huh7 cells 0, 0.25, 0.5, 1, 2, 4 μM 48 hours To evaluate the effect of ALW-II-41-27 on HCC cell proliferation, results showed that ALW significantly inhibited the growth of HCC cells. PMC7954228
Hep3B cells 0, 0.25, 0.5, 1, 2, 4 μM 48 hours To evaluate the effect of ALW-II-41-27 on HCC cell proliferation, results showed that ALW significantly inhibited the growth of HCC cells. PMC7954228
SNU449 cells 0, 0.25, 0.5, 1, 2, 4 μM 48 hours To evaluate the effect of ALW-II-41-27 on HCC cell proliferation, results showed that ALW significantly inhibited the growth of HCC cells. PMC7954228
H358 cells 1 μM 72 hours To evaluate the effect of ALW-II-41-27 on NSCLC cell viability, results showed that ALW-II-41-27 significantly reduced cell viability. PMC4001547
H2009 cells 1 μM 6 hours To evaluate the effect of ALW-II-41-27 on NSCLC cell signaling pathways, results showed that ALW-II-41-27 inhibited phosphorylation of S6K1, S6, and BAD. PMC4001547

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Yeast β-glucan-induced lung inflammation model Intraperitoneal injection 0.1 mg/kg 20 hours before and 2 hours after ALW-II-41-27 significantly reduced TNF-alpha protein levels in the lungs induced by yeast β-glucans PMC10848750
C57BL/6 mice Trichinella spiralis-infected mouse model Intraperitoneal injection 12.5, 25, 50, 100 mg/kg once daily for 7 consecutive days ALW-II-41-27 significantly decreased gastrointestinal motility and visceral sensitivity in Trichinella spiralis-infected mice and inhibited oxidative stress and inflammation PMC5890185
NSG mice HCC xenograft model Intraperitoneal injection 15 mg/kg once daily for seven days To evaluate the effect of ALW-II-41-27 on HCC tumor growth, results showed that ALW significantly inhibited tumor growth and even caused tumor regression. PMC7954228
Mice H358 xenograft model Intraperitoneal injection 15 mg/kg twice daily for 14 days To evaluate the effect of ALW-II-41-27 on NSCLC tumor growth, results showed that ALW-II-41-27 significantly inhibited tumor growth and induced tumor cell apoptosis. PMC4001547

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.65mL

0.33mL

0.16mL

8.23mL

1.65mL

0.82mL

16.46mL

3.29mL

1.65mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories